ABC | Volume 113, Nº6, December 2019

Original Article Celebi et al. NT-pro BNP and left ventricular aneurysm Arq Bras Cardiol. 2019; 113(6):1129-1137 Table 2 – Laboratory and angiographic parameters of the study group LV Aneurysm (-) LV Aneurysm (+) p- value NT-BNP, pg/mL 192.3 ± 176.6 523.5 ± 231.1 0.000 Gensini Score 38.7 ± 30.8 37.9 ± 29.9 0.924 Rentrop Score 1.96 ± 1.32 1.51 ± 0.76 0.000 Revascularization, % 72 45.5 0.021 Succesful Reperfusion, % 84.5 62.8 0.01 Killip 1.1 ± 0.3 1.5 ± 0.5 0.001 LVEF (%) 4.2 ± 8.6 32.3 ± 4.8 0.001 C r e atinine, mg/dl 0.9 ± 0.7 1.3 ± 0.8 0.02 MPV, fL 8.6 ± 0.8 9.3 ± 0.8 0.000 MCV, fL 85.0 ± 9.8 86.2 ± 10.7 0.683 Glucose, mg/dl 98.7 (IQR 62.0–312.0) 101.5 (IQR 66.0–427.0) 0.211 HbA1c, % 7.2 (IQR 5.8–13.1) 7.8 (IQR 6.5–14.8) 0.098 Peak cTnI, ng/mL 28.6 ± 19.2 43.4 ± 26.8 0.000 Peak CK-MB, IU/L 82.0 ± 54.30 212 ± 96.80 0.003 LVEF: Left ventricular ejection fraction; MPV: Mean platelet volume; MCV: mean corpuscular volume; IQR: Interquartile range; cTnI: cardiac troponine I; CK‑MB: creatinine kinase-MB. Categorical variables were compared by Pearson’s chi-square test or Fisher’s exact test, and continuous numerical variables were compared by the Student’s t test for independent sample or Mann-Whitney test, as appropriate. Table 3 – In hospital Therapy and Adverse Events LV Aneurysm(-) (n = 1259) (%) LV Aneurysm(+) (n = 157) (%) p-value P2Y12 inh. (1226) 97.3 (112) 71.3 0.008 LMWH (912)72.4 (97)61.7 0.008 Statin (124)98.6 (142)90.4 0.128 b-bloker (1208)96.0 (136)86.6 0.300 ACE inh (1041)82.6 (128)81.5 0.927 ARB (34)2.7 (9)5.7 0.075 Spironolakton (92)7.3 (22)14.0 0.128 Furosemide (167)13.2 (99)63.1 < 0.0001 Tiyazid (27)2.1 (14)8.9 0.050 CCB (59)4.7 (7)4.4 0.542 Amiodorone (67)5.3 (16)10.2 0.190 Digoxin (16)1.3 (21)13.3 0.035 Warfarin (75)5.9 (15)9.5 0.050 Insülin (101)8.0 (16)10.1 1.000 OAD (185)14.6 (7)4.4 0.205 Post MI angina (34)2.7 (8)5.0 0.542 Heart Failure (185)14.7 (93)59.2 0.01 Acut Renal Failure (44)3.3 (7)4.4 0.404 Pericarditis (51)4.0 (9)5.7 1.000 Arrythmia (251)20.0 (64)40.7 0.046 GIS bleeding (21)1.7 (4)2.5 1.000 Hematuri (14)1.1 (7)4.4 0.227 LV thrombus (23)1.8 (29)18.4 0.002 Mitral Regurgitation (167)13.2 57(36.3) 0.015 P2Y12 inh.: P2Y12 inhibitor; LMWH: Low molecular weight heparine; ACE inh.: angiotensin converting enzyme inhibitor; ARB: Angiotensin receptor blocker; CCB: Calcium channel Blockers; OAD: Oral antidiabetic; MI: myocardial infarction; GIS: Gasrointestinal system; LV: left Ventricle. Categorical variables were compared by Pearson’s chi-square test or Fisher’s exact test. 1133